Inflammation is increasingly recognized as an important modifier of prognosis in heart failure (HF). However, whether the association between statin therapy and outcomes varies by inflammatory risk and treatment duration remains uncertain.
To evaluate the association between statin therapy and clinical out...
A. Cai, Wen-Li Gu, K. Yiu· European Heart Journal· 0 citations
Combined aortic regurgitation (AR) and mitral regurgitation (MR) is a relatively common multiple valvular heart disease. Current guidelines recommend intervention (AVI and/or MVI) when either lesion becomes severe in the setting of symptoms, left ventricular (LV) systolic dysfunction or dilation, as in isolated s...
C. Ng, P. Santi, N. Elmasry et al.· European Heart Journal· 0 citations
GLP-1 receptor agonists confer pleiotropic vascular protection via mechanisms other than glycemic and body weight control. Comprehensive proteomic evaluations of its immunothrombosis modulatory and vascular effects remained limited.
To investigate the immunothrombosis modulatory effects of GLP-1 receptor a...
Y. Chan, S. Rakesh, T. Chan et al.· European Heart Journal· 0 citations
Among asymptomatic patients with moderate-severe or severe chronic AR and preserved LVEF, elevated LAP is independently associated with increased long-term mortality, suggesting that markers of elevated LV filling pressures may improve risk stratification of these patients.
P. Santi, N. Elmasry, J. Bernard et al.· European Heart Journal· 0 citations
In this large, global, real-world study, most patients with CAD at risk of a first MACE were undertreated with LLT and did not achieve recommended LDL-C levels, highlighting substantial gaps between guideline recommendations and real-world practice.
Q. Chan, J. Cegla, J. Cornel et al.· European Heart Journal· 0 citations
Patients with concurrent heart failure (HF) and type 2 diabetes mellitus (T2DM) have a markedly elevated cancer risk, yet the optimal glycemic control target for reducing oncologic risk in this population is unclear. Nonlinear relationships between glycemic markers and cancer outcomes have been suggested, but thi...
Y. Qi, Q. Ren, A. Mastumoto et al.· European Heart Journal· 0 citations
LASr, LAScd and LASb are significant independent predictors of MACE in CMR for assessing prognosis in HCM patients, and LGE quantification was not a significant independent predictor.
S. Ho, K. Yiu, K. Leung et al.· The International Journal of...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.